COVID-19 typically causes less severe illness and fewer deaths in children and adolescents compared to adults. Nonetheless, children and adolescents remain susceptible to COVID-19 infection and can transmit to others. In this touchINFECTIOUS DISEASES interview, we met with Dr Ruth Link-Gelles (Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA) to discuss real-world findings of vaccine effectiveness of third vaccine doses in people ages 5-17, effectiveness of maternal vaccines in pregnant people and infants <6 months, and vaccine effectiveness in children aged < 5 years.
Interviews available in this series:
Efficacy of COVID-19 vaccination in paediatric populations
Questions:
- What have real-world findings taught us about the effectiveness of third vaccine doses in people ages 5-17? (0:17)
- What have we learned about the effectiveness of maternal vaccines in pregnant people and infants <6 months during the delta and early omicron outbreaks? (0:40)
- What is known about vaccine effectiveness in children aged < 5 years? (1:14)
Disclosures: Ruth Link-Gelles has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
